Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP993150priorityCriticalpatent/ECSP993150A/en
Publication of ECSP993150ApublicationCriticalpatent/ECSP993150A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere al uso de ciertos derivados de pirido [1,2-a]- pirizina, también descritos como compuestos bis-azabicíclicos y definidos por la fórmula (I) de este documento, en el tratamiento de la enfermedad de parkinson, el trastorno de hiperactividad con déficit de atención y microademonas en mamíferos, y a composiciones relacionadas.The present invention relates to the use of certain pyrido [1,2-a] -pyrizine derivatives, also described as bis-azabicyclic compounds and defined by formula (I) herein, in the treatment of Parkinson's disease, attention deficit hyperactivity disorder and mammalian mammals, and related compositions.
ECSP9931501999-09-211999-09-21
PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PARKINSON'S DISEASE, ADHD AND MICROADENOMAS
ECSP993150A
(en)
SUBSTITUTED PIRAZOLO-QUINAZOLINA DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. PROCESS FOR THE PREPARATION AND USE OF THE SAME AS ANTICANCER AGENTS.